You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Details for New Drug Application (NDA): 200173


✉ Email this page to a colleague

« Back to Dashboard


NDA 200173 describes IMIQUIMOD, which is a drug marketed by Apotex Inc, Cosette, Encube, Fougera Pharms, Glenmark Generics, Padagis Israel, Strides Pharma, and Taro, and is included in nine NDAs. It is available from five suppliers. Additional details are available on the IMIQUIMOD profile page.

The generic ingredient in IMIQUIMOD is imiquimod. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the imiquimod profile page.
Summary for 200173
Tradename:IMIQUIMOD
Applicant:Taro
Ingredient:imiquimod
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 200173
Suppliers and Packaging for NDA: 200173
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMIQUIMOD imiquimod CREAM;TOPICAL 200173 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4145 51672-4145-6 24 PACKET in 1 CARTON (51672-4145-6) / .25 g in 1 PACKET (51672-4145-8)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength5%
Approval Date:Apr 15, 2011TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.